These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29800305)

  • 1. High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.
    Saravanan S; Gomathi S; Delong A; Kausalya B; Sivamalar S; Poongulali S; Brooks K; Kumarasamy N; Balakrishnan P; Solomon SS; Cu-Uvin S; Kantor R
    J Antimicrob Chemother; 2018 Aug; 73(8):2152-2161. PubMed ID: 29800305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.
    Ondoa P; Gautam R; Rusine J; Lutter R; Jurriaans S; Kootstra N; Karita E; van de Wijgert J
    PLoS One; 2015; 10(5):e0127201. PubMed ID: 26010956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.
    Kantor R; Bettendorf D; Bosch RJ; Mann M; Katzenstein D; Cu-Uvin S; D'Aquila R; Frenkel L; Fiscus S; Coombs R;
    PLoS One; 2014; 9(4):e93537. PubMed ID: 24699474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
    Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
    HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
    Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI
    J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
    Kantor R; DeLong A; Balamane M; Schreier L; Lloyd RM; Injera W; Kamle L; Mambo F; Muyonga S; Katzenstein D; Hogan J; Buziba N; Diero L
    J Int AIDS Soc; 2014; 17(1):19262. PubMed ID: 25413893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.
    Venkatesh KK; DeLong AK; Kantor R; Chapman S; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM; Cu-Uvin S
    J Womens Health (Larchmt); 2013 Apr; 22(4):330-8. PubMed ID: 23531097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART.
    Monno L; Punzi G; Scarabaggio T; Saracino A; Brindicci G; Fiore JR; Iambrenghi OC; Di Stefano M; Pastore G; Angarano G
    J Med Virol; 2003 May; 70(1):1-9. PubMed ID: 12629636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance in variants from the female genital tract and plasma.
    Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
    J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    Loubet P; Charpentier C; Visseaux B; Borbor A; Nuta C; Adu E; Chapplain JM; Baysah M; Tattevin P; Yazdanpanah Y; Descamps D
    J Antimicrob Chemother; 2015; 70(6):1881-4. PubMed ID: 25698771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
    Gonzalez-Serna A; Min JE; Woods C; Chan D; Lima VD; Montaner JS; Harrigan PR; Swenson LC
    Clin Infect Dis; 2014 Apr; 58(8):1165-73. PubMed ID: 24429436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals.
    Torti C; Quiros-Roldan ME; Cologni G; Nichelatti M; Ceresoli F; Pinti M; Nasi M; Cossarizza A; Lapadula G; Costarelli S; Manca N; Gargiulo F; Magoni M; Carosi G
    Curr HIV Res; 2008 Jan; 6(1):43-8. PubMed ID: 18288974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
    Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
    Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
    Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.
    Kantor R; Smeaton L; Vardhanabhuti S; Hudelson SE; Wallis CL; Tripathy S; Morgado MG; Saravanan S; Balakrishnan P; Reitsma M; Hart S; Mellors JW; Halvas E; Grinsztejn B; Hosseinipour MC; Kumwenda J; La Rosa A; Lalloo UG; Lama JR; Rassool M; Santos BR; Supparatpinyo K; Hakim J; Flanigan T; Kumarasamy N; Campbell TB; Eshleman SH;
    Clin Infect Dis; 2015 May; 60(10):1541-9. PubMed ID: 25681380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings.
    Gupta S; Neogi U; Srinivasa H; Shet A
    J Antimicrob Chemother; 2013 Sep; 68(9):2003-6. PubMed ID: 23633683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance.
    Canestri A; Ghosn J; Wirden M; Marguet F; Ktorza N; Boubezari I; Dominguez S; Bossi P; Caumes E; Calvez V; Katlama C
    Antivir Ther; 2006; 11(5):561-6. PubMed ID: 16964823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.